ConductScience.org, home

Gene · 10332

CLEC4M: C-type lectin domain family 4 member M

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. CLEC4M: C-type lectin domain family 4 member M. Genes, record 10332. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/10332

On this page

Gene

Symbol
CLEC4M
HGNC
Name
C-type lectin domain family 4 member M
HGNC
NCBI Gene ID
10332
NCBI Gene
HGNC ID
HGNC:13523
HGNC
Ensembl
ENSG00000104938
NCBI Gene
Aliases
CD209L, CD209L1, CD299, DC-SIGN2, DC-SIGNR, DCSIGNR, HP10347, L-SIGN, LSIGN
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9H2X3C-type lectin domain family 4 member M3997Ensembl, GeneID, HGNC

Source UniProt

Patents21

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1442493Q9H2X3Espacenet
EP 4641201 A22025-10-294633Q9H2X3Espacenet
JP 2025529142 A2025-09-041012Q9H2X3Espacenet
US 12371689 B22025-07-291012Q9H2X3Espacenet
JP 2025517969 A2025-06-124633Q9H2X3Espacenet
US 11446398 B22022-09-2020636Q9H2X3Espacenet
US 11400116 B22022-08-023899Q9H2X3Espacenet
JP 2022524081 A2022-04-27123607Q9H2X3Espacenet
JP 2022509929 A2022-01-25408Q9H2X3Espacenet
WO 2021222385 A12021-11-043Q9H2X3Espacenet

1 to 10 of 21

See all 21 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants914

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleCLEC4M papersNewest fiscal year
P30AI045008Penn Center for AIDS Research82025
ZIAAI001209The humoral response to Zika virus infection and vaccination82025
P51OD011132Emory National Primate Research Center52025
P01AI106695Protective immunity following dengue virus natural infections and vaccination42025
P30CA008748Cancer Center Support Grant42025
ZIAAI005047Influenza and Emerging and Re-emerging Infectious Diseases Vaccine Studies42025
P30AI027757University of Washington/Fred Hutch Center for AIDS Research32025
P30CA068485Cancer Center Support Grant32025
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant32025
P30DK063491Diabetes Research Center (DRC)32025

1 to 10 of 914Source NIH's project files

See all 914 nih grants

Papers1,514

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
[Corrigendum] CLEC4M overexpression inhibits progression and is associated with a favorable prognosis in hepatocellular carcinoma.Mol Med Rep202642695409PubTator, text miningPubMed
Whole genome sequencing to elucidate novel genetic modifiers of FVIII clearance.Blood202642636151PubTator, text miningPubMed
Integrating Bulk and Single-Cell RNA Sequencing to Identify Prognostic Genes Associated with Adaptive Immunity and the Tumor Microenvironment in Cholangiocarcinoma for Risk Model Construction.Immunobiology202642468280PubTator, text miningPubMed
Exploring SNPs in viral entry-related protein genes and their association with severe fever with thrombocytopenia syndrome virus infection risk.Microbiol Spectr202642454931PubTator, text miningPubMed
AI-Driven Discovery of Prototype CLEC4M Inhibitors Targeting Marburg Virus Entry via Integrated Machine Learning and Molecular Modeling.Int J Mol Sci202642353044PubTator, text miningPubMed
Chronic military stress and glandular epithelial tumor biology: an integrative neuroendocrine-inflammatory framework with insights from microgravity gene discovery.Front Oncol202642344694PubTator, text miningPubMed
Pathogenicity of Rift Valley fever virus: Organ-specific clinical outcomes and hidden drivers of virulence - a narrative review.Virulence202641928558PubTator, text miningPubMed
From a Multi-Omics Signature to a Therapeutic Candidate: Computational Prediction and Experimental Validation in Liver Fibrosis.Pharmaceuticals (Basel)202641901341PubTator, text miningPubMed
Immunoregulatory effect of metformin in monocytes exposed to SARS-CoV-2 spike protein subunit 1.Immunometabolism (Cobham)202641768486PubTator, text miningPubMed
Glycosylated carbon nanodots as multivalent blockers of lectin-driven viral entry: structural insights and antiviral performance.Nanoscale202641757861PubTator, text miningPubMed

1 to 10 of 1,514

See all 1,514 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/10332

GET https://conductscience.org/api/genes/v1/10332/patents?page=2